The global hand-held surgical instruments market size was estimated at USD 5.08 billion in 2021 and is projected to witness a compound annual growth rate (CAGR) of 7.2% from 2022 to 2030. The rising prevalence of chronic disorders, such as cardiovascular, urological, neurological, and infectious diseases are key factors driving the market. In addition, the growing geriatric population prone to various diseases is expected to indirectly propel the uptake of these instruments.
The COVID-19 pandemic had a significant negative impact on the hand-held surgical instruments market. The lockdowns, restrictions, and guidelines led down by government authorities across the globe in order to curb the spread of the COVID-19 virus led to a sudden downfall in the sales of hand-held surgical instruments. The healthcare guidelines led by the authorities suggested postponement of elective surgical procedures in order to avoid any potential compromise on hospital and intensive care unit capacity and shortages in personal protective equipment.
However, with the situation finally being under control in the second half of the pandemic, hospitals and other settings started performing surgical procedures in full volume. This has helped the market to recover in 2021. Significant backlogs in surgical procedures and increasing demand for elective surgeries is further expected to surge the demand for the hand-held surgical instruments market.
As compared to other chronic disorders, the prevalence of heart disorders is increasing worldwide due to lack of physical activity, overweight, smoking, poor nutrition, or family history. Other risk factors for cardiovascular disorders comprise diabetes, hypertension, or hyperlipidemia. According to CDC, about 20.1 million adults aged 20 and older had coronary artery disease in 2020. People aged 60 and above are at a high risk of diseases such as cardiovascular, orthopedic, and neurological diseases. Thus, an increase in the geriatric population is expected to boost the demand for handheld surgical equipment. In addition, an increase in the number of road accidents is one of the high-impact rendering factors leading to increase in the demand for handheld surgical instruments.
The increasing number of surgical procedures along with the growing demand for aesthetic surgeries is another driver of the hand-held surgical instruments market. Procedures, such as breast surgery, eyelid, liposuction, nose reshaping, tummy tuck surgeries have been witnessing high demand in over the past few years, which is propelling the uptake of hand-held surgical instruments, thereby driving the market. Growing innovations in surgical instruments and increasing adoption of advanced devices by surgeons is also predicted to drive the hand-held surgical instruments market over the forecast period. Surgeons are constantly focusing on using superior quality instruments that would allow them to perform surgeries smoothly and speedily with no compromise on the patient’s health. One such innovative surgical instrument is a technologically improved powered screwdriver specially designed for extremely sensitive surgeries. It has sensors incorporated with software that offers intelligence to the surgeon.
The forceps segment held the highest market share in 2021 at 18.7% owing to its increasing usage. The rise in usage is attributable to its advantages, such as; it helps in eliminating the need for holding minute objects with hands and avoiding contamination. The others segment includes clamps, bone chisel, closure devices, dissecting knife, bone saw, curette, osteotome, elevators and rongeur.
However, the retractors segment is expected to experience maximum growth at a CAGR of 9.3% over the forecast period owing to advancements in retractors for different types of surgeries. For instance, in September 2021, a trauma surgeon invented the TITAN CSR, a unique retractor that combines both ample exposure and speed. The product does not need to be mounted on the table and can be set up in about 6 seconds without losing any functionality.
The orthopedic surgery segment held the highest revenue share of 17.4% in 2021 due to factors such as; the high incidence of Musculoskeletal (MSK) ailments and increasing developments in minimally invasive surgeries. According to a research article by WHO published in July 2022, approximately 1.71 billion people have MSK conditions globally. It is the leading cause of disability worldwide, which hampers an individual’s productivity.
The plastic surgery segment is expected to be the fastest-growing segment at a CAGR of 7.6% over the forecast period. Factors such as technological advancements in plastic surgery that have made it safer and reduced the recovery time as well as the cost of the procedure have led to the growing popularity of plastic surgeries. Individuals are now not reluctant to undergo plastic surgery with fear as they would be before. Moreover, growing disposable income and the rising influence of social media are factors that are further driving the growth of this segment over the forecast period. For instance, according to the American Academy of Facial Plastic and Reconstructive Surgery, an estimated 1.4 million surgical and non-surgical procedures were performed in 2020. This indicated a 40 percent increase even though most countries were hit by the COVID-19 pandemic.
The hospitals segment held for highest revenue share in 2021 at 51.6% owing to a large number of cases and preventive surgeries being performed in these settings. In addition, the availability of all types of surgical instruments and skilled professionals is expected to fuel the segment growth. The rising number of admissions due to the increasing number of chronic disorders is also expected to propel the segment growth over the forecast period. With the increase in the number of procedures, such as angioplasty and kidney & liver transplants, and incidence of trauma, the demand for surgical equipment has significantly increased in hospitals.
The ambulatory surgical centers segment is expected to gain maximum growth over the forecast period. This is due to the growing popularity of aesthetic or cosmetic surgeries being carried out in ambulatory surgical centers. Moreover, it offers advantages like reduced cost by curtailing the overall patient stay post-procedure. Thus, making it a perfect option for individuals that do not need prolonged hospital stays, thereby fueling the market demand.
The clinics segment is also expected to experience significant growth over the forecast period due to the number of dental and orthopedic specialty clinics across the globe. Global rise in the prevalence of melanoma and skin cancer has led to a latent increase in the number of patients visiting dermatology clinics for treatment and care. Moreover, sprains, osteoporosis, cartilage tears, fractures, strains, osteoarthritis, and ankle arthritis are usually treated at orthopedic clinics as they offer expert advice and skill with respect to orthopedics. As orthopedic clinics cater to the needs of patients and provide customized services, they are preferred over hospitals that usually cater to a wide range of disorders and diseases.
North America dominated the global hand-held surgical instrument market with an overall market share of 41.0% in 2021. The increasing prevalence of neurological, cardiovascular, cancer, and autoimmune disorders is the key factor driving the market growth in this region. Some of the common surgeries performed in North America include circumcision, C-section, cataract removal, joint replacement, gallbladder removal, angioplasty, broken bone repair, and cardiovascular disorders. According to a research article published in the Journal of the American Medical Association, the U.S. had more than 13 million U.S. surgical procedures from the start of 2019 to Jan 30th, 2021.
Europe is expected to capture the second position owing to the increasing demand for safe surgical instruments that are used in minimally invasive surgeries. Growing demand for less time-consuming and cost-effective medical solutions are also expected to augment the demand for hand-held surgical instruments, thereby driving the market. According to WHO, the European region has the highest burden of non-communicable diseases and is expected to grow at a high rate in the near future.
The Asia Pacific is expected to witness lucrative growth owing to the growing population, high prevalence of chronic disorders, and increasing spending power of consumers. In addition, growing medical tourism in developing economies due to the lower cost of procedures as compared to other developed countries is driving the growth of the market in the Asia Pacific region. According to the Malaysia Healthcare Travel Council, a coronary artery bypass graft that would cost $92,000 in the United States costs less than $10,000 in India.
Key players in the hand-held surgical instruments market are carrying out various strategic initiatives in order to capture a strong market presence and extend their product reach across various countries. Acquisitions & mergers, partnerships and collaboration for marketing and sales of the products are some of the common initiatives that the market players are currently focusing on. For instance, in September 2022, Zimmer Biomet signed a multi-year co-marketing agreement with Surgical Planning Associates to commercialize its first FDA-approved mixed reality navigation system for total hip replacement.
In January 2021, Smith+Nephew completed the acquisition of the Extremity Orthopedics business of Integra Lifesciences Holdings Corporation in order to support its strategy of investing in higher-growth segments. Some of the prominent players in the hand-held surgical instruments market include:
Zimmer Biomet
B. Braun Melsungen AG
Integra LifeSciences Corporation
Medtronic, plc.
Smith & Nephew
Zimmer Biomet Holdings
Johnson & Johnson Services, Inc.
Becton, Dickinson and Company
CooperSurgical, Inc.
Thompson Surgical Instruments Inc.
Aspen Surgical
Report Attribute |
Details |
Market size value in 2022 |
USD 5.2 billion |
Revenue forecast in 2030 |
USD 9.6 billion |
Growth Rate |
CAGR of 7.2% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2017 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; India; Japan; Mexico; Brazil; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
B. Braun Melsungen AG; Integra LifeSciences Corporation; Medtronic; Smith & Nephew; Zimmer Biomet Holdings; Johnson & Johnson Services, Inc.; Becton; Dickinson and Company; CooperSurgical, Inc.; Thompson Surgical Instruments Inc.; Aspen Surgical |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global hand-held surgical instruments market report on the basis of product, application, end-use, and region:
<
Product Outlook (Revenue, USD Million, 2017 - 2030)
Forceps
Retractors
Dilators
Graspers
Scalpels
Cannulas
Dermatome
Trocars
Others
Application Outlook (Revenue, USD Million, 2017 - 2030)
Orthopedic Surgery
Cardiology
Ophthalmology
Wound Care
Audiology
Thoracic Surgery
Urology and Gynecology Surgery
Plastic Surgery
Neurosurgery
Others
End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global hand-held surgical instruments market size was estimated at USD 5.08 billion in 2021 and is expected to reach USD 5.2 billion in 2022.
b. The global hand-held surgical instruments market is expected to grow at a compound annual growth rate of 7.2% from 2022 to 2030 to reach USD 9.6 billion by 2030.
b. North America dominated the hand-held surgical instruments market with a share of 39.9% in 2021. This is attributable to the increasing incidence of chronic diseases such as cardiovascular diseases, neurological diseases, cancer, diabetes, and autoimmune diseases.
b. Some key players operating in the hand-held surgical instruments market include Zimmer Biomet Holdings; B. Braun Melsungen AG; Becton, Dickinson and Company; Integra LifeSciences Corporation; Smith & Nephew; Medtronic; CooperSurgical Inc.; Johnson & Johnson; Thompson Surgical Instruments Inc.; and Aspen Surgical.
b. Key factors that are driving the market growth include increasing prevalence of chronic diseases, rise in the number of road and other accidents, and rise in the number of surgical procedures across the world.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.